Tag Archive | "head and neck cancer"

Timing of Post-TX Imaging Key in Head, Neck Cancer

Wednesday, February 22, 2012

0 Comments

Source: MedScape Today Summary The investigators report on a systematic review and meta-analysis of 51 studies involving 2335 patients with head and neck squamous cell carcinoma who underwent post-treatment or surveillance with 18F-fluorodeoxyglucose (FDG) PET or FDG-PET/CT. The random-effects model-weighted mean pooled sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for detection [...]

Continue reading...

HPV a gender-neutral killer

Wednesday, February 15, 2012

0 Comments

Source: DailyPress.com Socially conservative lawmakers will likely repeal Virginia’s requirement that schoolgirls get vaccinated against a sexually transmitted virus called HPV that can, and now will, kill many of them. They’re repealing it in the name of sexual abstinence, family values and apple pie. In the name of keeping government out of private health-care decisions [...]

Continue reading...

Adaptive radiotherapy may benefit patients with head and neck cancer

Friday, February 10, 2012

0 Comments

Source: News-Medical.net Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer. The trial, sponsored by the National Cancer Institute, provides evidence that ART may benefit patients [...]

Continue reading...

Head and neck cancer carries substantial comorbidity burden

Monday, February 6, 2012

0 Comments

Source: MedWire News People with head and neck cancer experience a high burden of both acute and chronic comorbidity, shows an analysis of a large Dutch population-based cohort. The researchers therefore advise clinicians to account for patients’ comorbidity burden when assessing the risk-benefit profile for different treatment options. Sarah Landis (GlaxoSmithKline, London, UK) and co-workers [...]

Continue reading...

Newer radiation technology improves head and neck cancer patients’ long-term quality of life

Friday, January 27, 2012

0 Comments

Source: Eurekalert.org Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM. Intensity modulated radiation therapy, or IMRT, [...]

Continue reading...

Grape seed extract kills head and neck cancer cells, leaves healthy cells unharmed

Friday, January 27, 2012

0 Comments

Source: Colorado Cancer Blog Nearly 12,000 people will die of head and neck cancer in the United States this year and worldwide cases will exceed half a million. A study published this week in the journal Carcinogenesis shows that in both cell lines and mouse models, grape seed extract (GSE) kills head and neck squamous [...]

Continue reading...

Oral temperature changes in head and neck cancer patients predicts side effect severity

Thursday, January 26, 2012

0 Comments

Source: American Society for Radiation Oncology The abstract, “Pilot study of functional infrared imaging for early  detection of mucositis in locally advanced head and neck cancer  reated with chemoradiotherapy,” will be presented at the Head and  neck Society Meeting in Arizona today. This is a synopsis of that  presentation. Slight temperature increases of the oral mucus [...]

Continue reading...

Oral Sex Cancer Virus More Common in Men Than Women, Study Finds

Thursday, January 26, 2012

0 Comments

Source: Bloomberg.com About 10 percent of men and 3.6 percent of women are orally infected with human papillomavirus, which is acquired through oral sex and can cause cancer. There are two peaks in the age people are infected — 30 to 34 and 60 to 64, according to the study published today in the Journal [...]

Continue reading...

Fatal Infusion Reactions to Cetuximab: Role of Immunoglobulin E–Mediated Anaphylaxis

Thursday, January 19, 2012

0 Comments

Source: Journal of Clinical Oncology To the Editor: In Journal of Clinical Oncology, Tronconi et al1 report a fatal hypersensitivity reaction to cetuximab in a 63-year-old patient with metastatic colon cancer and outlined a 0.1% incidence of death in the literature. We greatly acknowledge the authors’ desire to communicate the risk of fatal anaphylactic reaction [...]

Continue reading...

Many Head and Neck Cancer Survivors Face Eating Problems

Tuesday, January 17, 2012

1 Comment

Source: HealthDay News Persistent pain, eating problems and depression are the most common problems experienced by long-term survivors of head and neck cancer, a new study finds. In the study, published in the Jan. 16 online issue of the journal Archives of Otolaryngology — Head & Neck Surgery, researchers looked at 337 people who were [...]

Continue reading...